tiprankstipranks
Trending News
More News >
Cryo-Cell International Inc (CCEL)
XASE:CCEL
US Market

Cryo-Cell International (CCEL) Ratios

Compare
53 Followers

Cryo-Cell International Ratios

CCEL's free cash flow for Q4 2025 was $0.78. For the 2025 fiscal year, CCEL's free cash flow was decreased by $ and operating cash flow was $-0.53. See a summary of the company’s cash flow.
Ratios
TTM
Nov 25Feb 25Nov 23Feb 23
Liquidity Ratios
Current Ratio
0.59 0.59 0.58 0.45 0.49
Quick Ratio
0.57 0.57 0.55 0.42 0.45
Cash Ratio
0.02 0.02 0.03 0.02 0.09
Solvency Ratio
-0.02 -0.02 0.01 -0.11 0.07
Operating Cash Flow Ratio
0.28 0.28 0.28 0.43 0.44
Short-Term Operating Cash Flow Coverage
2.01 2.01 1.63 6.42 3.54
Net Current Asset Value
$ -68.58M$ -68.58M$ -65.34M$ -62.80M$ -56.80M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.05 0.20 0.18 0.18
Debt-to-Equity Ratio
-0.17 -0.17 -0.98 -0.99 -7.62
Debt-to-Capital Ratio
-0.21 -0.21 -45.85 -80.59 1.15
Long-Term Debt-to-Capital Ratio
-0.03 -0.03 -1.69 -3.24 1.22
Financial Leverage Ratio
-3.32 -3.32 -4.89 -5.55 -42.57
Debt Service Coverage Ratio
0.12 0.12 -0.18 -2.50 1.55
Interest Coverage Ratio
0.23 0.23 1.87 -9.95 2.64
Debt to Market Cap
0.12 0.10 0.17 0.22 0.30
Interest Debt Per Share
0.65 0.65 1.82 1.45 1.55
Net Debt to EBITDA
6.00 6.00 8.70 -1.01 1.49
Profitability Margins
Gross Profit Margin
76.63%76.63%75.15%73.07%71.02%
EBIT Margin
-0.86%-0.86%2.94%-38.69%15.96%
EBITDA Margin
1.52%1.52%4.45%-33.24%21.92%
Operating Profit Margin
1.53%1.53%10.88%-39.26%13.27%
Pretax Profit Margin
-7.40%-7.40%8.77%-42.64%10.94%
Net Profit Margin
-7.70%-7.70%1.26%-30.38%9.14%
Continuous Operations Profit Margin
-7.70%-7.70%1.26%-30.38%9.14%
Net Income Per EBT
103.95%103.95%14.34%71.25%83.50%
EBT Per EBIT
-484.49%-484.49%80.57%108.62%82.47%
Return on Assets (ROA)
-3.94%-3.94%0.62%-15.55%4.27%
Return on Equity (ROE)
15.27%13.06%-3.04%86.32%-181.81%
Return on Capital Employed (ROCE)
1.15%1.15%8.08%-30.49%8.86%
Return on Invested Capital (ROIC)
1.04%1.04%1.06%-20.89%6.98%
Return on Tangible Assets
-4.12%-4.12%0.65%-16.33%5.80%
Earnings Yield
-9.21%-7.56%0.57%-21.34%7.49%
Efficiency Ratios
Receivables Turnover
0.00 0.00 4.38 4.77 5.02
Payables Turnover
2.57 2.57 4.22 2.66 5.48
Inventory Turnover
18.04 18.04 12.08 10.98 10.33
Fixed Asset Turnover
1.44 1.44 1.41 1.42 2.14
Asset Turnover
0.51 0.51 0.49 0.51 0.47
Working Capital Turnover Ratio
-4.26 -3.70 -3.13 -2.95 -4.00
Cash Conversion Cycle
-121.82 -121.82 27.17 -27.43 41.41
Days of Sales Outstanding
0.00 0.00 83.41 76.58 72.72
Days of Inventory Outstanding
20.23 20.23 30.20 33.24 35.34
Days of Payables Outstanding
142.05 142.05 86.44 137.25 66.64
Operating Cycle
20.23 20.23 113.61 109.82 108.06
Cash Flow Ratios
Operating Cash Flow Per Share
0.68 0.68 0.74 1.07 1.01
Free Cash Flow Per Share
0.65 0.65 0.44 0.15 -1.02
CapEx Per Share
0.03 0.03 0.30 0.92 2.03
Free Cash Flow to Operating Cash Flow
0.96 0.96 0.60 0.14 -1.00
Dividend Paid and CapEx Coverage Ratio
1.58 1.58 1.36 1.17 0.35
Capital Expenditure Coverage Ratio
23.77 23.77 2.50 1.17 0.50
Operating Cash Flow Coverage Ratio
1.71 1.71 0.46 0.82 0.74
Operating Cash Flow to Sales Ratio
0.17 0.17 0.19 0.28 0.28
Free Cash Flow Yield
19.92%16.34%5.12%2.87%-23.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-10.83 -13.22 175.31 -4.69 13.35
Price-to-Sales (P/S) Ratio
0.83 1.02 2.20 1.42 1.22
Price-to-Book (P/B) Ratio
-1.41 -1.73 -5.33 -4.05 -24.27
Price-to-Free Cash Flow (P/FCF) Ratio
5.00 6.12 19.54 34.84 -4.30
Price-to-Operating Cash Flow Ratio
4.80 5.86 11.73 5.00 4.32
Price-to-Earnings Growth (PEG) Ratio
0.03 0.02 -1.68 0.01 0.50
Price-to-Fair Value
-1.41 -1.73 -5.33 -4.05 -24.27
Enterprise Value Multiple
60.65 72.83 58.23 -5.29 7.05
Enterprise Value
29.23M 35.00M 82.87M 55.11M 46.90M
EV to EBITDA
60.81 72.83 58.23 -5.29 7.05
EV to Sales
0.93 1.11 2.59 1.76 1.55
EV to Free Cash Flow
5.57 6.67 22.97 43.03 -5.46
EV to Operating Cash Flow
5.33 6.39 13.79 6.18 5.47
Tangible Book Value Per Share
-2.65 -2.65 -1.98 -1.67 -2.20
Shareholders’ Equity Per Share
-2.31 -2.31 -1.63 -1.32 -0.18
Tax and Other Ratios
Effective Tax Rate
0.04 0.04 0.86 0.29 0.16
Revenue Per Share
3.91 3.91 3.93 3.76 3.58
Net Income Per Share
-0.30 -0.30 0.05 -1.14 0.33
Tax Burden
1.04 1.04 0.14 0.71 0.84
Interest Burden
8.63 8.63 2.98 1.10 0.69
Research & Development to Revenue
0.01 0.01 0.04 0.04 0.01
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 0.00 0.02 0.03 0.02
Income Quality
-2.26 -2.26 14.95 -0.94 3.09
Currency in USD